They demonstrated that cross-reactive B cells which recognize EBNA1 peptide 58–72 and Ro60 peptide 169–180 are involved in the initiation of anti-Ro60 antibody responses in SLE patients. Here, RO60 is linked to systemic lupus erythematosus.